Elekta (OTCMKTS:EKTAY) Announces Quarterly Earnings Results

Elekta (OTCMKTS:EKTAY) released its quarterly earnings results on Thursday. The company reported $0.09 earnings per share for the quarter, Zacks reports. The firm had revenue of $433.29 million during the quarter. Elekta had a return on equity of 12.14% and a net margin of 1.62%.

Elekta Stock Up 14.1%

Shares of OTCMKTS EKTAY traded up $0.83 during midday trading on Friday, reaching $6.69. 370 shares of the company’s stock were exchanged, compared to its average volume of 2,746. Elekta has a 52-week low of $4.35 and a 52-week high of $6.93. The stock has a market capitalization of $2.47 billion, a PE ratio of 95.60 and a beta of 1.07. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.79 and a current ratio of 1.04. The business’s fifty day moving average price is $6.29 and its two-hundred day moving average price is $5.58.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.